含有氧化锌的乳膏产品缓解蚊虫叮咬症状的有效性和安全性。

IF 1.6 4区 医学 Q3 OPHTHALMOLOGY
Cutaneous and Ocular Toxicology Pub Date : 2023-12-01 Epub Date: 2023-07-12 DOI:10.1080/15569527.2023.2234030
Vu Nguyet Minh, Vu Hai Yen, Dinh Thi Hoa, Nguyen Thi Huong, Bui Quang Hao
{"title":"含有氧化锌的乳膏产品缓解蚊虫叮咬症状的有效性和安全性。","authors":"Vu Nguyet Minh,&nbsp;Vu Hai Yen,&nbsp;Dinh Thi Hoa,&nbsp;Nguyen Thi Huong,&nbsp;Bui Quang Hao","doi":"10.1080/15569527.2023.2234030","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>People frequently experience discomfort with immediate wheal, delayed papules, and pruritus from mosquito bites. A topical cream product containing zinc oxide is commercially available for the management of insect bites, but there has been no published evidence for its effectiveness and safety.</p><p><strong>Aims: </strong>To evaluate the effectiveness and safety of this product in symptoms caused by mosquito bites.</p><p><strong>Methods: </strong>An open-label, controlled study was performed on 41 healthy participants. All subjects received <i>Aedes aegypti</i> mosquito bites on the forearm. Then test product was randomly applied to the bitten areas of the left or right arm. The other arm was left untreated (control). The onset of pruritus relief was noted. The severity of pruritus was assessed using a visual analogue scale (VAS), ranging from 0 mm (no pruritus) to 100 mm (severe pruritus), and a 4-point pruritus score (0 = none; 1 = mild, not affecting normal activities; 2 = moderate, affecting normal activities to some extent; 3 = severe, significantly affecting activities) at four time points: 15 minutes after the mosquito bite (baseline), as well as 1 hour, 24 hours, and 48 hours after initiating treatment. The size of the bite reaction lesion was also measured at all time points. Any local cutaneous adverse reactions observed during the study were documented.</p><p><strong>Results: </strong>The onset of pruritus relief in the treated group (25 ± 21.7 minutes) was significantly faster compared to the untreated group (118.7 ± 304.8 minutes). The reduction in VAS score at 1 hour was significantly greater in the product group (30.5 ± 16.22) compared to the control group (14.9 ± 9.9). Moreover, there was a significant difference in the reduction of pruritus score at 1 hour, with the product group (1.1 ± 0.5) showing a higher reduction compared to the control group (0.3 ± 0.4). However, there was no significant difference in the reduction of bite lesion size between the two groups. Throughout the study, no adverse events were reported.</p><p><strong>Conclusion: </strong>Our preliminary findings indicate that the product effectively reduces pruritus caused by mosquito bites but does not have a significant impact on the size of the bite lesions. The product was found to be safe and may be an option for managing mosquito bites pruritus.</p>","PeriodicalId":11023,"journal":{"name":"Cutaneous and Ocular Toxicology","volume":" ","pages":"209-212"},"PeriodicalIF":1.6000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effectiveness and safety of a cream product containing zinc oxide for alleviating mosquito bite symptoms.\",\"authors\":\"Vu Nguyet Minh,&nbsp;Vu Hai Yen,&nbsp;Dinh Thi Hoa,&nbsp;Nguyen Thi Huong,&nbsp;Bui Quang Hao\",\"doi\":\"10.1080/15569527.2023.2234030\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>People frequently experience discomfort with immediate wheal, delayed papules, and pruritus from mosquito bites. A topical cream product containing zinc oxide is commercially available for the management of insect bites, but there has been no published evidence for its effectiveness and safety.</p><p><strong>Aims: </strong>To evaluate the effectiveness and safety of this product in symptoms caused by mosquito bites.</p><p><strong>Methods: </strong>An open-label, controlled study was performed on 41 healthy participants. All subjects received <i>Aedes aegypti</i> mosquito bites on the forearm. Then test product was randomly applied to the bitten areas of the left or right arm. The other arm was left untreated (control). The onset of pruritus relief was noted. The severity of pruritus was assessed using a visual analogue scale (VAS), ranging from 0 mm (no pruritus) to 100 mm (severe pruritus), and a 4-point pruritus score (0 = none; 1 = mild, not affecting normal activities; 2 = moderate, affecting normal activities to some extent; 3 = severe, significantly affecting activities) at four time points: 15 minutes after the mosquito bite (baseline), as well as 1 hour, 24 hours, and 48 hours after initiating treatment. The size of the bite reaction lesion was also measured at all time points. Any local cutaneous adverse reactions observed during the study were documented.</p><p><strong>Results: </strong>The onset of pruritus relief in the treated group (25 ± 21.7 minutes) was significantly faster compared to the untreated group (118.7 ± 304.8 minutes). The reduction in VAS score at 1 hour was significantly greater in the product group (30.5 ± 16.22) compared to the control group (14.9 ± 9.9). Moreover, there was a significant difference in the reduction of pruritus score at 1 hour, with the product group (1.1 ± 0.5) showing a higher reduction compared to the control group (0.3 ± 0.4). However, there was no significant difference in the reduction of bite lesion size between the two groups. Throughout the study, no adverse events were reported.</p><p><strong>Conclusion: </strong>Our preliminary findings indicate that the product effectively reduces pruritus caused by mosquito bites but does not have a significant impact on the size of the bite lesions. The product was found to be safe and may be an option for managing mosquito bites pruritus.</p>\",\"PeriodicalId\":11023,\"journal\":{\"name\":\"Cutaneous and Ocular Toxicology\",\"volume\":\" \",\"pages\":\"209-212\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cutaneous and Ocular Toxicology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/15569527.2023.2234030\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/7/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cutaneous and Ocular Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15569527.2023.2234030","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/12 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:人们经常因蚊虫叮咬而出现即时风团、延迟性丘疹和瘙痒等不适。含有氧化锌的外用乳膏产品可用于治疗昆虫叮咬,但尚未公布其有效性和安全性的证据。目的:评价本品治疗蚊虫叮咬症状的有效性和安全性。方法:对41名健康受试者进行开放性对照研究。所有受试者前臂均被埃及伊蚊叮咬。然后将测试产品随机应用于左臂或右臂的被咬区域。另一只手臂未经治疗(对照组)。注意到瘙痒缓解的发作。使用视觉模拟量表(VAS)评估瘙痒的严重程度,范围为0 mm(无瘙痒)至100 mm(严重瘙痒),瘙痒评分为4分(0 = 没有一个1. = 温和,不影响正常活动;2. = 中度,在一定程度上影响正常活动;3. = 严重、严重影响活动)在四个时间点:15 蚊子叮咬后几分钟(基线),以及1 小时,24 小时和48 开始治疗后数小时。在所有时间点也测量了咬合反应损伤的大小。记录研究期间观察到的任何局部皮肤不良反应。结果:治疗组瘙痒发作缓解(25 ± 21.7 分钟)明显快于未治疗组(118.7 ± 304.8 分钟)。VAS评分降低1 产品组的小时数显著增加(30.5 ± 16.22)与对照组(14.9 ± 9.9)。此外,在1 小时,与产品组(1.1 ± 0.5),显示出与对照组(0.3)相比更高的减少 ± 0.4)。然而,两组之间在减少咬合损伤大小方面没有显著差异。在整个研究过程中,未报告任何不良事件。结论:我们的初步研究结果表明,该产品能有效减少蚊子叮咬引起的瘙痒,但对叮咬部位的大小没有显著影响。该产品被发现是安全的,可能是治疗蚊虫叮咬瘙痒的一种选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Effectiveness and safety of a cream product containing zinc oxide for alleviating mosquito bite symptoms.

Background: People frequently experience discomfort with immediate wheal, delayed papules, and pruritus from mosquito bites. A topical cream product containing zinc oxide is commercially available for the management of insect bites, but there has been no published evidence for its effectiveness and safety.

Aims: To evaluate the effectiveness and safety of this product in symptoms caused by mosquito bites.

Methods: An open-label, controlled study was performed on 41 healthy participants. All subjects received Aedes aegypti mosquito bites on the forearm. Then test product was randomly applied to the bitten areas of the left or right arm. The other arm was left untreated (control). The onset of pruritus relief was noted. The severity of pruritus was assessed using a visual analogue scale (VAS), ranging from 0 mm (no pruritus) to 100 mm (severe pruritus), and a 4-point pruritus score (0 = none; 1 = mild, not affecting normal activities; 2 = moderate, affecting normal activities to some extent; 3 = severe, significantly affecting activities) at four time points: 15 minutes after the mosquito bite (baseline), as well as 1 hour, 24 hours, and 48 hours after initiating treatment. The size of the bite reaction lesion was also measured at all time points. Any local cutaneous adverse reactions observed during the study were documented.

Results: The onset of pruritus relief in the treated group (25 ± 21.7 minutes) was significantly faster compared to the untreated group (118.7 ± 304.8 minutes). The reduction in VAS score at 1 hour was significantly greater in the product group (30.5 ± 16.22) compared to the control group (14.9 ± 9.9). Moreover, there was a significant difference in the reduction of pruritus score at 1 hour, with the product group (1.1 ± 0.5) showing a higher reduction compared to the control group (0.3 ± 0.4). However, there was no significant difference in the reduction of bite lesion size between the two groups. Throughout the study, no adverse events were reported.

Conclusion: Our preliminary findings indicate that the product effectively reduces pruritus caused by mosquito bites but does not have a significant impact on the size of the bite lesions. The product was found to be safe and may be an option for managing mosquito bites pruritus.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.30
自引率
6.20%
发文量
40
审稿时长
1 months
期刊介绍: Cutaneous and Ocular Toxicology is an international, peer-reviewed journal that covers all types of harm to cutaneous and ocular systems. Areas of particular interest include pharmaceutical and medical products; consumer, personal care, and household products; and issues in environmental and occupational exposures. In addition to original research papers, reviews and short communications are invited, as well as concise, relevant, and critical reviews of topics of contemporary significance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信